Short-Term Atorvastatin Treatment Improves Endothelial Function in Hypercholesterolemic Women
Authors:
- Graziana LupattelliGLGraziana Lupattelli
- Donatella SiepiDSDonatella Siepi
- Giuseppe SchillaciGSGiuseppe Schillaci
- Gaetano VaudoGVGaetano Vaudo
- Anna Rita RosciniARAnna Rita Roscini
- Helmut SinzingerHSHelmut Sinzinger
- Elmo MannarinoEMElmo Mannarino
- 1 November 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 36 (5) , 617-621
Abstract
Endothelial dysfunction represents the earliest stage of atherosclerosis and is usually present in hypercholesterolemia. Treatment with statins has been shown to normalize endothelial function in middle-aged men with hypercholesterolemia. We evaluated the effect over time of atorvastatin on the endothelial reactivity in postmenopausal hypercholesterolemic women (mean age. 58 ± 6 years), receiving atorvastatin, 10 mg daily (n = 20) or American Heart Association step 1 diet (n = 10) for 8 weeks. Lipid profile and brachial artery flow-mediated vasodilation (FMV) were determined at baseline and after 1, 2, 4, and 8 weeks. FMV increased progressively in subjects treated with atorvastatin, and the difference was significant (p < 0.05 vs. baseline) after the second week (baseline 3.8 ± 3%; first week, 4.8 ± 3%; second week, 9.2 ± 3%; fourth week, 11.0 ± 3%; eighth week, 11.7 ± 3%). No significant changes were observed in subjects receiving diet (baseline, 3.1 ± 4%; first week, 2.4 ± 2%; second week, 2.9 ± 2%; fourth week, 3.1 ± 2%; eighth week, 3.3 ± 2%; p = NS). In the atorvastatin group, low-density lipoprotein (LDL) cholesterol showed a significant decrease since the first week (baseline, 228 ± 37 mg/dl; first week, 171 ± 32; second week, 147 ± 27; fourth week, 139 ± 29; eighth week, 135 ± 27; all p < 0.05). In the control group, LDL cholesterol showed a smaller but significant (p < 0.05) reduction after the second week (baseline, 226 ± 17 mg/dl; first week, 225 ± 16; second week, 220 ± 17; fourth week, 203 ± 27; eighth week, 198 ± 27). In conclusion, hypercholesterolemic women treated with atorvastatin show a significant improvement in endothelial reactivity after as early as 2 weeks of therapy. The extent to which these beneficial effects are attributable to cholesterol reduction or to a direct effect of the drug remains to be established.Keywords
This publication has 25 references indexed in Scilit:
- Impaired endothelial function in arterial hypertension and hypercholesterolemiaJournal Of Hypertension, 2000
- Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged menThe American Journal of Cardiology, 1996
- Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in womenJACC, 1994
- Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patientsJACC, 1994
- Hypercholesterolemia increases endothelial superoxide anion production.Journal of Clinical Investigation, 1993
- Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemiaThe Lancet, 1992
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992
- The Simultaneous Generation of Superoxide and Nitric Oxide Can Initiate Lipid Peroxidation in Human Low Density LipoproteinFree Radical Research Communications, 1992
- Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta.Journal of Clinical Investigation, 1990
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986